5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis.

Shuji HibiyaYusuke MatsuyamaToshimitsu FujiiChiaki MaeyashikiEiko SaitoKimiko ItoHiromichi ShimizuAmi KawamotoMaiko MotobayashiKento TakenakaMasakazu NagahoriMasayuki KurosakiTsunehito YauchiKazuo OhtsukaTakeo FujiwaraRyuichi OkamotoMamoru Watanabe

Published in: Alimentary pharmacology & therapeutics (2020)

Patients in whom 5-ASA was discontinued due to intolerance had a higher risk of undergoing colectomy than patients tolerant to their first, second or third 5-ASA compounds.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
ulcerative colitis